22 Informaciones Psiquiátricas 2024 - n.º 253 26. Stein SR, Ramelli SC, Grazioli A, Chung JY, Singh M, Yinda CK, et al. SARSCoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022; 612(7941): 758-763. 27. Kumar S, Veldhuis A, & Malhotra T. Neuropsychiatric and cognitive sequelae of COVID-19. Front Neurol. 2021; 12. 28. Douaud G, Lee S, Alfaro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022; 604(7907): 697-707. 29. Díez M, Yus M, Gómez N, Polidura C, Gil L, Delgado C, et al. Multimodal neuroimaging in post-COVID syndrome and correlation with cognition. Brain. 2022; 146(5): 2142-2152. 30. Goehringer F, Bruyere A, Doyen M, Bevilacqua S, Charmillon A, Heyer S. et al. Brain 18F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics. Eur J Nucl Med Mol Imaging. 2022; 50(4): 1084-1089. 31. Hosp JA, Dressing A, Blazhenets G, Bormann T, Rau A, Schwabenland M, et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021; 144(4): 1263-127. 32. Hugon J, Msika EF, Queneau M, Farid K & Paquet C. Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J Neurol. 2022; 269(1): 44-46. 33. Sociedad Española de Médicos Generales y de Familia & Long Covid ACTS. [Internet]. Encuesta COVID-19 Persistente. 2020. Recuperado a partir de: https://www.semg.es/images/2020/ Noticias/20201111_Resultados_Encuesta_COVID_Persistente.pdf 34. Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021; 38. Ane Iturrate / José Ignacio Quemada / Naiara Mimentza
RkJQdWJsaXNoZXIy MzkyOTU=